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Continuous process technologies are available for essentially every step in a fully integrated continuous 
downstream processing platform. Most of these technologies have a significantly higher throughput and specific 
productivity than their batch equivalent process steps. The consequence is that the amount of material required 
to run experiments during continuous process development work is significantly higher than in batch process 
development. 
 
High throughput experimentation platforms have been established for performing design of experiments studies 
for many batch downstream processing steps, but for the equivalent continuous bioprocessing technologies this 
doesn’t exist. This limits the amount of different process variations that can be tested as part of the process 
characterization studies.  
 
In this presentation, we will analyze a continuous monoclonal antibody purification platform, using the Quality by 
Design approach to identify the key process parameters and critical process parameters. Based on the process 
knowledge and process design information available for the various continuous bioprocessing technologies, we 
will analyze how these critical process parameters translate into a continuous bioprocessing platform for 
monoclonal antibodies.  
 
 
